APIS Assay Technologies Company
Introducing APIS Assay Technologies APIS is leveraging systems biology, interrogating multi-OMICs biodata, and deploying innovative ‘Clickmer’ ligand binding technology, for the validation and translation of biomarker and therapeutic assets into clinical utility.
Industry:
Diagnostics
Estimated Revenue:
£780 000 - £7 800 000
Headquarters:
Manchester, Manchester, United Kingdom
Employee Number:
11-50
Total Funding:
£23 000 000
Founded Date:
2018